Stock indexes are moderately higher today on carryover support from Monday's sharp gains in hopes that next week's upcoming US reciprocal tariffs would be more targeted than previously stated and ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...

Use your computer. The form may not open on tablets or mobile phones. Save the form on your computer in a place you can remember. For most Internet browsers, clicking on the link above will ...

Dr. Matushansky, an experienced oncologist and drug development expert, will lead the clinical strategies for Immuneering’s cancer drug programs, including the ongoing Phase 2a trial of IMM-1-104, the ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer ...